Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

693319

registered interest
date	22/02/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what evidence NHS England used to reach the decision to set the proposed budget impact threshold for new medicines at £20million.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	65172
answer	answer is ministerial correction date of answer 02/03/2017 answer text <p>The proposed budget impact threshold is intended to help to ensure that technologies with a large budget impact can be introduced in a phased way that does not displace other effective treatments for NHS patients. NHS England has advised that the proposed budget impact threshold was based on consideration of the frequency and magnitude of high budget impact technologies that have recently received a recommendation from the National Institute for Health and Care Excellence (NICE). An analysis of positive technology appraisals published between June 2015 and June 2016 reveals that around 80% of new technologies recommended by NICE fell below the proposed budget impact threshold.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 02/03/2017 10:30:09 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1521 label Biography information for Mrs Sharon Hodgson

155926

registered interest
date	17/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking with NHS England and the National Institute for Health and Care Excellence to help local drugs and therapeutics networks to improve access to off-patent drugs.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	214770
answer	answer is ministerial correction date of answer 24/11/2014 answer text <p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p><br> We are in the process of setting up a round-table discussion with key stakeholders, including NHS England and the National Institute for Health and Care Excellence to explore opportunities for supporting appropriate use of off-label drugs outside their licensed indications where the evidence supports this.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/11/2014 17:33:51 answering member 4020 label Biography information for George Freeman
tabling member	1521 label Biography information for Mrs Sharon Hodgson